| Financial Year |
March 31 2023 |
| Monetary Funds |
145,099,453.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
145,082,283.79 |
| Advances to Suppliers |
6,250,694.44 |
| Other Receivables |
17,414,930.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
40,021,162.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,370,000.00 |
| Other Current Assets |
18,251,973.08 |
| Total Current Assets |
511,170,744.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,588,100.78 |
| Long-term Equity Investment |
137,423,916.95 |
| Investment Properties |
8,513,852.95 |
| Fixed Assetes |
1,962,647,037.90 |
| Under-construction Projects |
69,814,205.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
148,551.75 |
| R&D expenses |
-- |
| Goodwill |
37,432,610.19 |
| Long-Term Deferred and Prepaid Expenses |
21,812,405.87 |
| Deferred Income Tax Assets |
412,366.88 |
| Other Non-Current Assets |
84,556,397.92 |
| Sub-Total of Non-Current Assets |
2,384,522,959.66 |
| Total Assets |
2,895,693,704.36 |
| Short-Term Loans |
340,432,416.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,511,172.46 |
| Accounts Payable |
153,588,462.29 |
| Accounts Received In Advance |
15,290.52 |
| Employee Compensation Payable |
18,671,005.32 |
| Taxes Payable |
10,973,535.46 |
| Interest Payable |
-- |
| Dividend Payable |
17,319,333.30 |
| Other payables |
40,184,537.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
229,303,044.07 |
| Other Current Liabilities |
44,112.61 |
| Sub-Total of Current Liabilities |
813,204,055.61 |
| Long-term Loans |
274,783,179.93 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
206,524,863.48 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,885,463.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
531,849,640.59 |
| Total Liabilities |
1,345,053,696.20 |
| Paid-In Capital(Or Share Stock) |
171,061,333.00 |
| Capital Surplus |
745,259,723.57 |
| Surplus Reserve |
59,831,114.82 |
| LESS:Treasury Stock |
21,943,920.00 |
| Undistributed Profits |
559,553,352.28 |
| Minority Stockholder's Interest |
38,061,515.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,512,578,492.77 |
| Owner's Equity（Stockholder's Equity） |
1,550,640,008.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,895,693,704.36 |
